🔎 Trials Near Me

Gara Jalqabaatti › Dhukkuba Kroonii › Utah

Qorannoo klinikaalii Dhukkuba Kroonii Utah keessatti

Qorannoo 8 Dhukkuba Kroonii f Utah keessatti hirmaatuu jiru.

Magaalota Utah keessatti

Takkalaa qorannoo (Ingiliffa)

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

  • Care Access - Ogden /ID# 266428, Ogden
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06548542

A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

  • University of Utah, Salt Lake City
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 3 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06663332

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

  • Velocity Clinical Research, Salt Lake City-Site Number: 8400147, West Jordan
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 16 hanga 80 · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT07184931

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

  • Care Access Research - Ogden, Ogden
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 85 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT06226883

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

  • University of Utah Health, Salt Lake City
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT06045754

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

  • University of Utah Health, Salt Lake City
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Hag-2026 · NCT05230173

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

  • University of Utah, Salt Lake City
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 27-Elb-2026 · NCT06456593

A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease

  • Investigational Site Number: 8400016, Ogden
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 27-Bit-2026 · NCT06958536

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.